UPDATE : Monday, June 18, 2018
IVI gets $6.46-million grant to test single-dose impact of HPV vaccine
The International Vaccine Institute, a nonprofit international organization...
by Marian Chu  |  2018-05-10 17:47
‘Open innovation a must in new drug development'
The government and pharmaceutical experts from the business, academic, rese...
by So Jae-hyeon  |  2018-05-10 16:05
Dong-A ST posts ₩135.6 billion in Q1 sales
Dong-A ST said Wednesday that it recorded 135.6 billion won ($126.7 million...
by Lee Han-soo  |  2018-05-10 15:05
Dong-A ST wins nod for testing overactive bladder treatment
The Ministry of Food and Drug Administration said it has approved Dong-A ST...
by Lee Hye-seon  |  2018-05-10 13:30
Daewoong to co-market SK Chemicals’ shingles vaccine
Ahn Jae-yong (right), senior vice president and head of SK Chemicals VAX bu...
by Lee Han-soo  |  2018-05-10 13:29
GenBody builds diagnostic kit production firm in Indonesia
GenBody said Wednesday it poured $430,000 into building a two-story diagnos...
by Marian Chu  |  2018-05-10 09:14
How are Korean drugmakers faring in US?
Major Korean drugmakers such as Daewoong Pharmaceutical, Huons, Hanmi Pharm...
by So Jae-hyeon  |  2018-05-09 15:55
Ministry puts Dong-A ST’s foot treatment on reference drug list
Dong-A ST said Wednesday that the Ministry of Food and Drug Safety (MFDS) h...
by Lee Han-soo  |  2018-05-09 15:37
Hanmi wins FDA nod for arthritis treatment Hyalrheuma
Hanmi Pharmaceutical said its self-developed arthritis treatment Hyalrheuma...
by So Jae-hyeon  |  2018-05-09 11:59
Bio & Medical Korea 2018 opens May 9
Acting President Hwang Kyo-an (center) and other dignitaries cut ribbons to...
by Lee Han-soo  |  2018-05-08 17:59
Spectra to market Huons’ local anesthetics in US
Huons said Monday that it has signed an agreement with Spectra Medical, Huo...
by Lee Han-soo  |  2018-05-08 16:35
Boryung’s antihypertensive drug Kanarb tops output among new drugs
Boryung Pharmaceutical’s antihypertensive treatment Kanarb ranked No. 1 in ...
by So Jae-hyeon  |  2018-05-08 16:05
Daewoong to seek US nod for liver drug Ursa this year
Daewoong Pharmaceutical said its liver drug Ursa was likely to become the c...
by So Jae-hyeon  |  2018-05-08 14:37
Does Celltrion’s biosimilar have price edge over Roche’s Herceptin?
Competition has been intensifying in the breast cancer therapy market due t...
by Marian Chu  |  2018-05-04 18:15
Janssen Korea gets prostate cancer drug reimbursed as 2nd line therapy
ZYTIGA Janssen Korea said that its prostate cancer therapy ZYTIGA (ingred...
by Marian Chu  |  2018-05-04 17:01
Daewoong compares Nabota with Botox in US, Mexico
Daewoong Pharmaceutical is actively promoting Nabota, an injectable type A ...
by Lee Hye-seon  |  2018-05-04 14:27
AstraZeneca Korea’s antiplatelet therapy gets insurance coverage
AstraZeneca Korea said Thursday that a 60 mg dose of its oral antiplatelet ...
by Marian Chu  |  2018-05-04 11:56
Hanmi posts ₩245.7 billion in Q1 sales
Hanmi Pharmaceutical said Thursday that it recorded 245.7 billion won ($228...
by Lee Han-soo  |  2018-05-03 14:52
How much cheaper will Keytruda be as first-line treatment?
The pharmaceutical industry is paying attention to how much the price of MS...
by Nam Doo-hyun  |  2018-05-03 14:51
SK Chemicals approves spinoff of its vaccine biz
SK Chemicals said Thursday that the company’s board of directors has approv...
by Lee Han-soo  |  2018-05-03 14:33
Back to Top